FindTrial
Sign In

Effects of TMC3115 Bifidobacterium Bifidum on Intestinal Flora and Lipid and Glucose Metabolism of Human

Effects of TMC3115 Bifidobacterium Bifidum on Intestinal Flora and Lipid and Glucose Metabolism of Human

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16010271
Enrollment
Unknown
Registered
2016-12-28
Start date
2017-01-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

historical control:Take probiotics

Sponsors

West China School of Public Health, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Randomly selected 40 elderly people in Chengdu, which meet the following requirements: 1. Middle-aged with BMI 18.5 ~ 23.9kg/m2, while the elderly 20.0 ~ 26.9kg/m2; 2. The levels of total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) or fasting blood glucose is higher or abnormal.

Exclusion criteria

Exclusion criteria: 1. Antibiotics were administered within 3 months before the start of the study; 2. Suffering from organic disease or a major disease; 3. Can not tolerate this test.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;Blood indicators;—

Countries

China

Contacts

Public ContactMing Li

West China School of Public Health, Sichuan University

ldmancheng@163.com+86 13096397110

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026